Recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky’s take in his latest column for the Omnicell blog

The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report sponsor).

“It could be at least a few months before we see concrete action” in manufacturers’ and provider groups’ contract pharmacy-related suits against the U.S. Health and Human Services Department (HHS), and in contract pharmacy-related proceedings providers initiated under the new 340B program administrative dispute resolution (ADR) system, Slafsky said. Community health centers and HIV/AIDS clinics have paused their contract pharmacy lawsuits against HHS to let the ADR process play out.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer